Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation; a Retrospective Analysis

NCT02084160 is registered in ClinicalTrials.gov with Meridian Bioscience, Inc. as lead sponsor.

NCT NCT02084160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02084160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation; a Retrospective Analysis
Lead sponsor
Meridian Bioscience, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2014
Completion date
November 30, 2018
Enrollment
579 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease